First Hospital of China Medical University
198
46
57
38
Key Highlights
Risk & Performance
Pipeline Risk Assessment
Pipeline Risk Assessment
Based on historical performance
Moderate Risk
Score: 45/100
1.5%
3 terminated/withdrawn out of 198 trials
92.7%
+6.2% vs industry average
12%
24 trials in Phase 3/4
8%
3 of 38 completed trials have results
Key Signals
Enrollment Performance
Analytics
Activity Timeline
Global Presence
Clinical Trials (198)
Local Hyperthermia Combined With Topical 3% Hydrogen Peroxide for Refractory Viral Warts
Role: lead
Epalrestat Combined With HAIC, Donafenib and Tislelizumab as First-line Treatment for Patients With Unresectable HCC and Diabetes - A Multicenter, Prospective, Single-arm Clinical Study
Role: collaborator
Proximal Gastrectomy vs Total Gastrectomy in Locally Advanced Upper Gastric Cancer After Neoadjuvant Therapy
Role: collaborator
Hyperthermia Combined With Hydrogen Peroxide Microneedle Patch for Viral Warts
Role: lead
Laparoscopic Staging for Stage III Gastric Cancer
Role: collaborator
Clinical Study of Venetoclax Combined With CACAG Regimen in the Treatment of Relapsed/Refractory Acute Myeloid Leukemia
Role: collaborator
Clinical Observation of Xeligekimab in the Treatment of Moderate to Severe Palmoplantar Pustulosis
Role: lead
The Chinese Familial Alzheimer's Network
Role: collaborator
China Cognition and Aging Study
Role: collaborator
Conversion Therapy With FOLFOX-HAIC Plus Lenvatinib And Tislelizumab For Hepatocellular Carcinoma With Vp3 Portal Vein Tumor Thrombus
Role: lead
Efficacy and Mechanisms of Escitalopram in Drug-Naïve First-Episode Major Depressive Disorder
Role: collaborator
Precision Reperfusion Therapy for Disabling Minor Stroke With Large Vessel Occlusion Beyond Time Window
Role: lead
Becotatug Vedotin Plus Sintilimab in Locoregionally Advanced NPC
Role: collaborator
A Hierarchical Multi-modal AI Framework for Pathological and Genetic Subtyping of Lung Cancer Based on PET/CT Imaging
Role: collaborator
Protocolized Weaning of High-Flow Nasal Cannula in Adult Patients
Role: collaborator
Artificial Intelligence-assisted HER2 Expression Assessment in Urothelial Carcinoma Based on Imaging-pathology Omics
Role: collaborator
18F-FDG PET/CT Radiomics Models for Precision Diagnosis and Prognosis in NSCLC
Role: collaborator
Biomarkers for Predicting the Response to Inhaled Corticosteroid in Patients With Chronic Cough.
Role: collaborator
Postoperative Radiotherapy for Early-stage Oral Tongue Squamous Cell Carcinoma Patients With Risk Factors: a Prospective, Multicenter, Randomized Controlled, Open-labelled Trial
Role: collaborator
HAIC in Combination With PD-1 Inhibitors and Lenvatinib for High Tumor Burden Advanced HCC (CHANCE2416)
Role: lead